These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35110475)

  • 1. Successful Management of a Young Athlete with Type 2 Long QT Syndrome by Genotype-specific Risk Stratification and Bridging Therapy with a Wearable Cardioverter Defibrillator.
    Kojima K; Kato K; Fujii Y; Okuyama Y; Ohno S; Ozawa T; Horie M; Nakagawa Y
    Intern Med; 2022 Apr; 61(8):1179-1182. PubMed ID: 35110475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wearable cardioverter defibrillators for patients with long QT syndrome.
    Owen HJ; Bos JM; Ackerman MJ
    Int J Cardiol; 2018 Oct; 268():132-136. PubMed ID: 30041777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
    Kaspar G; Sanam K; Gholkar G; Bianco NR; Szymkiewicz S; Shah D
    Int J Cardiol; 2018 Dec; 272():179-184. PubMed ID: 30121177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.
    Andresen H; Sasko B; Patschan D; Pagonas N; Ritter O
    J Med Case Rep; 2021 May; 15(1):243. PubMed ID: 33993888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention with the implantable cardioverter-defibrillator in high-risk long-QT syndrome patients.
    Biton Y; Rosero S; Moss AJ; Goldenberg I; Kutyifa V; McNitt S; Polonsky B; Baman JR; Zareba W
    Europace; 2019 Feb; 21(2):339-346. PubMed ID: 29947754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and Management of Athletes With Long QT Syndrome.
    Gomez AT; Prutkin JM; Rao AL
    Sports Health; 2016; 8(6):527-535. PubMed ID: 27480102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome.
    Schneider HE; Steinmetz M; Krause U; Kriebel T; Ruschewski W; Paul T
    Clin Res Cardiol; 2013 Jan; 102(1):33-42. PubMed ID: 22821214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA; Vermilye K; Moss AJ; Goldenberg I; Klein HU; McNitt S; Zareba W; Kutyifa V
    Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I; Erath JW; Russo AM; Burch AE; Assmus B; Bonderman D; McNitt S; Kutyifa V
    Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM; Bense J; Hohenforst-Schmidt W
    J Interv Card Electrophysiol; 2021 Nov; 62(2):401-407. PubMed ID: 33200285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
    Spar DS; Bianco NR; Knilans TK; Czosek RJ; Anderson JB
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006163. PubMed ID: 29945928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An optimized long QT syndrome differentiating protocol: A new indication for wearable cardioverter-defibrillator vests.
    Pilawa M; Kaźmierczak J; Kiedrowicz RM
    Kardiol Pol; 2022; 80(7-8):857-858. PubMed ID: 35677993
    [No Abstract]   [Full Text] [Related]  

  • 16. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M; Weyand M; Seitz T; Harig F
    Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13048. PubMed ID: 36723848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation.
    Healy CA; Carrillo RG
    Heart Rhythm; 2015 Jul; 12(7):1565-73. PubMed ID: 25839113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter defibrillator treatment in long QT syndrome patients: a national study on adherence to international guidelines.
    Sundström E; Jensen SM; Diamant UB; Rydberg A
    Scand Cardiovasc J; 2017 Apr; 51(2):88-94. PubMed ID: 27936942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: Clinical and economic implications.
    Boriani G; Mantovani LG; Cortesi PA; De Ponti R; D'Onofrio A; Arena G; Curnis A; Forleo G; Guerra F; Porcu M; Sgarito G; Botto GL
    Clin Cardiol; 2021 Nov; 44(11):1497-1505. PubMed ID: 34427926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators in patients with long QT syndrome: a multicentre study.
    Zienciuk-Krajka A; Sterliński M; Filipecki A; Owczuk R; Bednarek J; Kempa M; Sielski S; Dziduszko M; Mitkowski P; Kaźmierczak J; Kuśnierz J; Michałkiewicz D; Stec SM; Gułaj M; Majcherek R; Lubiński A; Raczak G
    Kardiol Pol; 2018; 76(12):1687-1696. PubMed ID: 30251242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.